跳至主要内容
临床试验/NCT02117908
NCT02117908已完成不适用

Application of CPAP to Reduce Complications and Improve Treatment of Radiofrequency Ablation of Lung Cancer Under Conscious Sedation. A Randomized Study

Sara Varea2 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2014年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
47
试验地点
2
主要终点
Number of Participants with Adverse Events as a Measure of Safety

研究概览

简要总结

The project aims to study whether the application of a continuous positive airway pressure (CPAP) of 4 cm water vapor is a safe method in pulmonary radiofrequency intervention (PRF) lung cancer under conscious sedation compared with placebo. And, assess whether CPAP prevents atelectasis formation and consequently reduces the potential complications of PRF and improves procedural success

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male and female aged 18 years and older
  • Patient with a scheduled intervention for ablation of pulmonary malignant tumor with radiofrequency .
  • Patient able to undergo tests and examinations required by the study.

排除标准

  • Patients with CPAP intolerance test.
  • Patients with progressive disease in which local treatment is not applicable
  • Patients with intercurrent process (pleural effusion, pneumonia, ...).
  • Patient unable to understand the proceedings.
  • Pregnancy or breastfeeding.

研究组 & 干预措施

CPAP +4 cm H2O

Experimental

CPAP +4 cm H2O pressure using ResMedTM face mask

干预措施: RESMED AUTOSET S9 (Device)

ShamCPAP

Sham Comparator

shamCPAP using ResMedTM CPAP face mask modified for technical sham

干预措施: RESMED AUTOSET S9 (Device)

结局指标

主要结局

Number of Participants with Adverse Events as a Measure of Safety

时间窗: thirty days

Patients with any of the following complications Pulmonary over-distention along intervention Pneumothorax along intervention Bronchial fistulas measures Computed tomography (CT)1, CT2 and CT3 Vomiting along intervention Decrease in MAP (mean arterial pressure) \> 20% measured in the intraoperative period Assay of each of the previous complications

次要结局

  • Treatment success(Measurement time: CT3)
  • Prevention of atelectasis.(during surgery)
  • Decrease associated complications with PFR. Measurement times: intraoperative, PACU (post-anesthesic care unit), hospital discharge, day 15 and day 30.(thirty days)
  • Predictors factors of the occurrence of complications during PRA (pulmonary radiofrequency ablation).(thirty days)

研究者

发起方
Sara Varea
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Sara Varea

Clinical Research Manager

Fundacion Clinic per a la Recerca Biomédica

研究点 (2)

Loading locations...

相似试验